Difference between revisions of "Involucrin (TG5)"
m |
|||
| (6 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
| − | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
| − | |||
| − | |||
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
| − | | | + | | Involucrin |
|- | |- | ||
| Synonyms | | Synonyms | ||
| Line 23: | Line 21: | ||
|- | |- | ||
| Reactive glutamines | | Reactive glutamines | ||
| − | | Q465, Q489, Q496 | + | | Q288, Q465, Q489, Q495, Q496 |
|- | |- | ||
| Reactive lysines | | Reactive lysines | ||
| Line 29: | Line 27: | ||
|- | |- | ||
| Substrate sequence | | Substrate sequence | ||
| − | | | + | | YLE''Q''QEGQLK |
| − | + | PKNLE''Q''EE''K''QLELP | |
| − | |||
| − | + | VKHLE''K''QEA''Q''LELPE | |
| − | + | LELPE''QQ''VGQPK | |
| − | + | LEQQE''K''HLEHP | |
|- | |- | ||
| Structure | | Structure | ||
| Line 54: | Line 51: | ||
| | | | ||
|- | |- | ||
| − | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
| − | [[Category: | + | [[Category:TG5|*]] |
Latest revision as of 12:07, 10 March 2015
| Involucrin (TG5) | |
|---|---|
| Substrate peptide name | Involucrin |
| Synonyms | - |
| Determination type | In situ |
| Source | Homo sapiens |
| Subcellular localization | Cornified envelope |
| Swissprot ID | P07476 |
| Reactive glutamines | Q288, Q465, Q489, Q495, Q496 |
| Reactive lysines | K468, K485, K508 |
| Substrate sequence | YLEQQEGQLK
PKNLEQEEKQLELP VKHLEKQEAQLELPE LELPEQQVGQPK LEQQEKHLEHP |
| Structure | No available crystal structure |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:8999895 |
| Notes | |
